Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bemfola vs Fostipur in oocyte donation program
2015-002214-77Phase 4Active
- Sponsor
- International Vaccine Institute
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial comparing Bemfola arm with Fostipur arm (2 arms). Primary endpoints: Number of metaphase II oocytes and Percentage of apoptosis in cumulus cells. Started Sep 2015; status: active.
02
Drugs
recombinant human follicle stimulating hormoneurofollitropin
Beyond the preview
Go deeper on 2015-002214-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002214-77.